Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.58 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.52 |
| ▸ | TRPA1 | O75762 | 4/20 | 0.50 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | GFER | P55789 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14644971 | 1.00 | TAAR1 (0.58) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL23710142 | 1.00 | TAAR1 (0.58) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL5609717 | 0.80 | RIPK1 (0.57) | TAAR1AOC3TRPA1RIPK1 | |
| SCHEMBL3672929 | 0.78 | TRPA1 (0.67) | TAAR1AOC3TRPA1RIPK1KDM4E | |
| SCHEMBL6280516 | 0.78 | RIPK1 (0.67) | TAAR1AOC3TRPA1RIPK1 | |
| SCHEMBL20082901 | 0.77 | ACHE (0.48) | TAAR1ALDH1A1 | |
| SCHEMBL16360942 | 0.77 | RIPK1 (0.53) | TAAR1AOC3TRPA1RIPK1 | |
| SCHEMBL5609879 | 0.77 | RIPK1 (0.53) | TAAR1AOC3TRPA1RIPK1 | |
| SCHEMBL17453236 | 0.76 | TAAR1 (0.61) | TAAR1AOC3TRPA1RIPK1ALDH1A1 | |
| SCHEMBL4443642 | 0.76 | TAAR1 (0.61) | TAAR1AOC3TRPA1RIPK1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 102 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6225370-B1 | FOR USE WITH INK JET PRINTERS | LEXMARK INTERNATIONAL, INC. | 2001-05-01 | — | — | US | claimed |
| US-20240229262-A1 | Gold-Doped Nickel Nanocluster, Preparation Method Therefor, and Use Thereof | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY (KR) | 2024-07-11 | — | — | US | disclosed |
| WO-2024117205-A1 | BICYCLIC PYRIDINE DERIVATIVE AND SALT THEREOF, AND HARMFUL ORGANISM CONTROL AGENT CHARACTERIZED BY CONTAINING SAID DERIVATIVE OR SALT THEREOF AS ACTIVE INGREDIENT | 北興化学工業株式会社 | 2024-06-06 | — | — | WO | disclosed |
| EP-3842074-A1 | PROTEIN-DRUG CONJUGATES | Philogen S.p.A. (IT) | 2021-06-30 | — | — | EP | disclosed |
| WO-2020227168-A1 | INHIBITING TRABID | INTEGRAL EARLY DISCOVERY, INC. (US) | 2020-11-12 | — | — | WO | disclosed |
| CN-111101094-A | Method for repairing furnace tube inner wall oxide layer on line | 中国石油化工股份有限公司 | 2020-05-05 | — | — | CN | disclosed |
| US-10351492-B2 | Introduction of alkyl substituents to aromatic compounds | B. G. NEGEV TECHNOLOGIES AND APPLICATIONS (IL) | 2019-07-16 | — | — | US | disclosed |
| WO-2018193463-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF TETRAHYDROISOQUINOLINE COMPOUNDS | NEON LABORATORIES LIMITED (IN) | 2018-10-25 | — | — | WO | disclosed |
| EP-3259249-A1 | INTRODUCTION OF ALKYL SUBSTITUENTS TO AROMATIC COMPOUNDS | B.G. Negev Technologies & Applications Ltd., at Ben-Gurion University (IL) | 2017-12-27 | — | — | EP | disclosed |
| US-9683015-B2 | Peptide C alpha-amides, methods for preparing same and uses thereof as precursors of peptide C alpha-thioesters for protein synthesis | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE-CNRS (FR) | 2017-06-20 | — | — | US | disclosed |
| US-4902707-A | Bicyclic pyrazolidinones, compositions and use | ELI LILLY AND COMPANY (US) | 1990-02-20 | — | — | US | disclosed |
| US-4826992-A | MICROBIOCIDE INTERMEDIATES | ELI LILLY AND COMPANY (US) | 1989-05-02 | — | — | US | disclosed |
| US-4795815-A | BACTERICIDES, MICROBIOCIDES | ELI LILLY AND COMPANY (US) | 1989-01-03 | — | — | US | disclosed |
| US-4734504-A | 1-alkylated diazolidinones | ELI LILLY AND COMPANY (US) | 1988-03-29 | — | — | US | disclosed |
| US-4734505-A | 1-(alkylated)-2-(acylated)diazolidinones | ELI LILLY AND COMPANY (US) | 1988-03-29 | — | — | US | disclosed |
| US-4716232-A | 1-(vinyl phosphonate adduct) pyrazolidinones | ELI LILLY AND COMPANY (US) | 1987-12-29 | — | — | US | disclosed |
| EP-0203722-A1 | Bicyclic pyrazolidinones | ELI LILLY AND COMPANY (US) | 1986-12-03 | — | — | EP | disclosed |
| EP-0203723-A1 | 2,3-(dihydro)bicyclic pyrazolidinones | ELI LILLY AND COMPANY (US) | 1986-12-03 | — | — | EP | disclosed |
| EP-0202046-A1 | 7-Substituted bicyclic pyrazolidinones | ELI LILLY AND COMPANY (US) | 1986-11-20 | — | — | EP | disclosed |
| EP-0104432-A2 | Herbicide and plant growth regulator comprising alpha-beta-unsaturated compound | TEIJIN LIMITED (JP) | 1984-04-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10351492-B2 | Introduction of alkyl substituents to aromatic compounds | TST, NAT1, CBS | TAAR1 444/4885AOC3 115/4885TRPA1 16/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.